rs538622 near ERGIC1, originally identified as a shared risk locus for ALS and FTD, has also previously been demonstrated to contribute to quantitative‐trait modification in ALS by relating to reduced expression of the protein BNIP1 in ALS patient motor neurons (Karch et al, 2018). This evidence concerns the gene BNIP1 and amyotrophic lateral sclerosis.